Physician profile
Otto O Yang
NPI 1780604298
$472,450.59
in general payments reported to CMS, 2019-2025
5 companies · $61K in 2025
The $61K reported for 2025 was more than what 98% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $66K · 2021: $66K · 2022: $66K · 2023: $67K · 2024: $81K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $155K · Consulting Fee: $51K · Travel and Lodging: $1,175 · Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $155,365.00 |
| Consulting Fee | $51,015.00 |
| Travel and Lodging | $1,174.63 |
| Food and Beverage | $579.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Corporation | $418,167.52 | 2019-2025 | |
| Applied Medical Resources Corporation | $54,261.72 | 2019-2025 | |
| Pfizer INC. | $21.35 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Research and ownership
$2,424,671.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Otto Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.